An alternative manner of crossing biological pathways is through the crossing of generalized biochemical responses rather than single TF signatures (e.g., HIF1α vs hypoxia and PCa vs AR) via both in vitro and in vivo data. The gene discussed is TF; the disease is posterior cortical atrophy.